Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photodynamic Therapy For Onychomycosis

NCT: NCT07756671 · NOT_YET_RECRUITING

NCT IDNCT07756671
StatusNOT_YET_RECRUITING
Start Date2026-08-10
Completion2027-12-31
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is clinical and mycological clearance of onychomycosis using photodynamic therapy (PDT) with aminolevulinic acid (ALA) 10% gel at 6 months, 3 months, 9 months and 12 months

Frequently Asked Questions

What is Photodynamic Therapy For Onychomycosis?

Photodynamic Therapy For Onychomycosis is a clinical trial registered under NCT07756671. Current status: NOT_YET_RECRUITING.

What is the status of NCT07756671?

The current status of NCT07756671 (Photodynamic Therapy For Onychomycosis) is: NOT_YET_RECRUITING.

When did Photodynamic Therapy For Onychomycosis start?

Photodynamic Therapy For Onychomycosis started on 2026-08-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.